TARPLIN, DOWNS & YOUNG, LLC for VERTEX PHARMACEUTICALS INCORPORATED
What was lobbied
6 issue areas, each in the filer's own words, with who lobbied on it and where.
Science/Technology SCI
Regulatory and legislative issues related to the U.S. Food and Drug Administration; appropriations for the U.S. Food and Drug Administration, the National Institutes of Health and the U.S. Centers for Disease Control; Medicare and Medicaid reimbursement issues; regulatory and legislative issues related to the U.S. Patent and Trademark Office.
| Lobbyist | Covered position, as disclosed |
|---|---|
| RAISSA H DOWNS New | CMTE. |
| ISAAC A FORDJOUR New | N/A |
| LINDA E TARPLIN New | SP. ASST. TO THE PRES. FOR LEG. AFFAIRS; DEP. ASST. SEC. FOR |
| JENNIFER B YOUNG New | AND MEANS; CMTE. STAFF, SEN. CMTE ON FINANCE |
Copyright/Patent/Trademark CPT
Regulatory and legislative issues related to the U.S. Food and Drug Administration; appropriations for the U.S. Food and Drug Administration, the National Institutes of Health and the U.S. Centers for Disease Control; Medicare and Medicaid reimbursement issues; regulatory and legislative issues related to the U.S. Patent and Trademark Office.
| Lobbyist | Covered position, as disclosed |
|---|---|
| RAISSA H DOWNS New | CMTE. |
| ISAAC A FORDJOUR New | N/A |
| LINDA E TARPLIN New | SP. ASST. TO THE PRES. FOR LEG. AFFAIRS; DEP. ASST. SEC. FOR |
| JENNIFER B YOUNG New | AND MEANS; CMTE. STAFF, SEN. CMTE ON FINANCE |
Health Issues HCR
Regulatory and legislative issues related to the U.S. Food and Drug Administration; appropriations for the U.S. Food and Drug Administration, the National Institutes of Health and the U.S. Centers for Disease Control; Medicare and Medicaid reimbursement issues; regulatory and legislative issues related to the U.S. Patent and Trademark Office.
| Lobbyist | Covered position, as disclosed |
|---|---|
| RAISSA H DOWNS New | CMTE. |
| ISAAC A FORDJOUR New | N/A |
| LINDA E TARPLIN New | SP. ASST. TO THE PRES. FOR LEG. AFFAIRS; DEP. ASST. SEC. FOR |
| JENNIFER B YOUNG New | AND MEANS; CMTE. STAFF, SEN. CMTE ON FINANCE |
Medicare/Medicaid MMM
Regulatory and legislative issues related to the U.S. Food and Drug Administration; appropriations for the U.S. Food and Drug Administration, the National Institutes of Health and the U.S. Centers for Disease Control; Medicare and Medicaid reimbursement issues; regulatory and legislative issues related to the U.S. Patent and Trademark Office.
| Lobbyist | Covered position, as disclosed |
|---|---|
| RAISSA H DOWNS New | CMTE. |
| ISAAC A FORDJOUR New | N/A |
| LINDA E TARPLIN New | SP. ASST. TO THE PRES. FOR LEG. AFFAIRS; DEP. ASST. SEC. FOR |
| JENNIFER B YOUNG New | AND MEANS; CMTE. STAFF, SEN. CMTE ON FINANCE |
Budget/Appropriations BUD
Regulatory and legislative issues related to the U.S. Food and Drug Administration; appropriations for the U.S. Food and Drug Administration, the National Institutes of Health and the U.S. Centers for Disease Control; Medicare and Medicaid reimbursement issues; regulatory and legislative issues related to the U.S. Patent and Trademark Office.
| Lobbyist | Covered position, as disclosed |
|---|---|
| RAISSA H DOWNS New | CMTE. |
| ISAAC A FORDJOUR New | N/A |
| LINDA E TARPLIN New | SP. ASST. TO THE PRES. FOR LEG. AFFAIRS; DEP. ASST. SEC. FOR |
| JENNIFER B YOUNG New | AND MEANS; CMTE. STAFF, SEN. CMTE ON FINANCE |
Medical/Disease Research/Clinical Labs MED
Regulatory and legislative issues related to the U.S. Food and Drug Administration; appropriations for the U.S. Food and Drug Administration, the National Institutes of Health and the U.S. Centers for Disease Control; Medicare and Medicaid reimbursement issues; regulatory and legislative issues related to the U.S. Patent and Trademark Office.
| Lobbyist | Covered position, as disclosed |
|---|---|
| RAISSA H DOWNS New | CMTE. |
| ISAAC A FORDJOUR New | N/A |
| LINDA E TARPLIN New | SP. ASST. TO THE PRES. FOR LEG. AFFAIRS; DEP. ASST. SEC. FOR |
| JENNIFER B YOUNG New | AND MEANS; CMTE. STAFF, SEN. CMTE ON FINANCE |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.